Cooper Pharma Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 02-01-2025
- Paid Up Capital ₹ 1.00 Cr
as on 02-01-2025
- Company Age 35 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.12 Cr
as on 02-01-2025
- Satisfied Charges ₹ 10.00 Cr
as on 02-01-2025
- Revenue 17.97%
(FY 2022)
- Profit 32.42%
(FY 2022)
- Ebitda 21.30%
(FY 2022)
- Net Worth 12.87%
(FY 2022)
- Total Assets 10.93%
(FY 2022)
About Cooper Pharma
The Corporate was formerly known as Cooper Pharma Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹3.12 Cr. The company has closed loans amounting to ₹10.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rakesh Bhargava, Abhishek Bhargava, and Dinesh Kumar serve as directors at the Company.
- CIN/LLPIN
U24231DL1989PLC034902
- Company No.
034902
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
02 Feb 1989
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Cooper Pharma Limited offer?
Cooper Pharma Limited offers a wide range of products and services, including Pain Relief Drugs & Pharmaceuticals, Muscle Relaxant, Anti Infective Drugs & Medicines, Antibacterial Drugs, Osteoporosis Medications, Diclofenac, Respiratory System Drugs, Anti Asthma Drug, Chemical Reagents & Catalysts, Ammonium Compound.
Who are the key members and board of directors at Cooper Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rakesh Bhargava  | Managing Director | 02-Feb-1989 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Abhishek Bhargava | Whole-Time Director | 01-Aug-2009 | Current |
| Dinesh Kumar | Director | 05-Jun-2024 | Current |
Financial Performance of Cooper Pharma.
Cooper Pharma Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 17.97% increase. The company also saw a substantial improvement in profitability, with a 32.42% increase in profit. The company's net worth Soared by an impressive increase of 12.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cooper Pharma?
In 2023, Cooper Pharma had a promoter holding of 99.81% and a public holding of 0.19%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Cooper Life Sciences Private LimitedActive 11 years 8 monthsRakesh Bhargava and Abhishek Bhargava are mutual person
Cooper Biotech Private LimitedActive 3 years 1 monthRakesh Bhargava and Abhishek Bhargava are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 04 Jul 2018 | ₹0.99 M | Open |
Punjab National Bank Creation Date: 26 Apr 2011 | ₹0.25 M | Open |
Small Industries Developmnt Bank Of India Creation Date: 28 Mar 2006 | ₹3.00 Cr | Open |
How Many Employees Work at Cooper Pharma?
Cooper Pharma has a workforce of 119 employees as of Aug 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cooper Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cooper Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
